Table 1 from Coevolution of Atypical <i>BRAF</i> and <i>KRAS</i> Mutations in Colorectal Tumorigenesis
Woolley CE., Domingo E., Fernandez-Tajes J., Pennel KAF., Roxburgh P., Edwards J., Richman SD., Maughan TS., Kerr DJ., Soriano I., Tomlinson IPM.
<p>Clinicopathologic and molecular summary information for <i>BRAF</i>-mutant patients in the combined cohort, stratified by functional classes 1, 2, and 3. The presence of concomitant pathogenic mutations in <i>KRAS</i>, <i>NRAS</i>, or <i>NF1</i> is shown for each class. In addition to the data in the table, a single instance of co-occurring class 2 and 3 <i>BRAF</i> mutations was found. Unclassified mutations are assumed to be passenger changes for the purpose of our analysis. WT <i>BRAF</i> colorectal cancers within the combined cohort are included for reference. Percentages shown in parentheses reflect the proportion of total samples with available data for a given variable.</p>